• Researcher Profile

    Wolfram Goessling, MD, PhD

    Wolfram Goessling, MD, PhD


    Associate Professor of Medicine, Harvard Medical School
    Assistant Professor of Health Sciences and Technology, Harvard Medical School


    Gastrointestinal Cancer

    Office phone: 617-632-3474
    Fax: 617-632-2260
    Website: www.fishing4stemcells.org

    Preferred contact method: office phone

    View Physician Profile

    Research Department

    Medical Oncology/Solid Tumor Oncology

    Area of Research

    Genetics causes of liver cancer and liver disease

    Dana-Farber Cancer Institute
    450 Brookline Avenue
    Boston, MA 02215

    Recent Awards

    • International Society for Stem Cell Research Travel Award, 2009
    • William R. Hearst Young Investigator Award, Brigham and Womens Hospital, 2009
    • Young Investigator Award: George Brecher Prize, International Society of Experimental Hematology, 2008
    • New Investigator Award, Mount Desert Island, 2006-2007
    • 29th Friends of Dana-Farber Cancer Institute Fellow, 2004-2005
    • Noah T. Herndon and Irving Janock Fellowships in Gastrointestinal Cancer, 2003-2004


    Genetics causes of liver cancer and liver disease

    Developmental signaling pathways govern the formation and function of stem cells, thereby holding the key to unlocking the promise of adult tissue regeneration, and to inhibiting cancer development. In our laboratory, we use zebrafish as the primary model to study the liver and explore the regulation of endodermal progenitor cell specification, organ differentiation and growth. We then examine the conserved role of these signaling pathways in regulating tissue growth in surgical and chemical models of liver regeneration and genetic liver cancer models. We also use murine liver injury models to demonstrate evolutionary conservation and relevance for human disease. Our prior work has shown that we can translate our findings from the fish tank to the bedside, as the first clinical trial originating from our findings in the fish has begun to enroll patients.

    We have found that the wnt pathway is an important regulator of liver development and regeneration. Recently, we showed that prostaglandin signaling interacts with wnt, offering a chance to therapeutically modify wnt-mediated stem and progenitor cell growth. In an effort to identify new pathways and genes important for liver development, we performed a genetic screen and characterized several mutants with disturbed liver formation. In addition, we are proceeding with a chemical genetic screen to characterize regulators of liver growth. We aim to use these findings and genomic analyses of clinical cohorts to better understand the interaction of regulatory signals that affect liver function and regeneration. The work in our laboratory is directly relevant for developing new treatment options for patients with liver failure and liver cancer.

View Researcher Directory
View Nurse Directory

Find a Clinical Trial

Support Cancer

Give Now